Journal of Pharmaceutical and Biomedical Analysis

SJR Rank #9,777H-index: 160SJR: 0.604Best quartile: Q2APC: US$3,680
Journal website: aims, scope and author guidelines
Publisher

Elsevier B.V.

Country

Netherlands

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • Analytical ChemistryQ2
  • Drug DiscoveryQ2
  • Pharmaceutical ScienceQ2
  • SpectroscopyQ2
  • Clinical BiochemistryQ3

Areas: Biochemistry, Genetics and Molecular Biology · Chemistry · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Analytical Chemistry and ChromatographyAnalytical Methods in PharmaceuticalsAntibiotics Pharmacokinetics and EfficacyMetabolomics and Mass Spectrometry StudiesMicrofluidic and Capillary Electrophoresis ApplicationsAnalytical Chemistry and SensorsPesticide Residue Analysis and SafetyTraditional Chinese Medicine AnalysisMass Spectrometry Techniques and ApplicationsNatural product bioactivities and synthesis

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs045090013501800

Documents per Year

202220250150300450600

Detailed Information

ISSN

0731-7085, 1873-264X

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

3.66

References per Document

35.26

Coverage

1983-2026

Scope

This journal is an international medium directed towards the needs of academic, clinical, government and industrial analysis by publishing original research reports and critical reviews on pharmaceutical and biomedical analysis. It covers the interdisciplinary aspects of analysis in the pharmaceutical, biomedical and clinical sciences, including developments in analytical methodology, instrumentation, computation and interpretation. Submissions on novel applications focusing on drug purity and stability studies, pharmacokinetics, therapeutic monitoring, metabolic profiling; drug-related aspects of analytical biochemistry and forensic toxicology; quality assurance in the pharmaceutical industry are also welcome. Studies from areas of well established and poorly selective methods, such as UV-VIS spectrophotometry (including derivative and multi-wavelength measurements), basic electroanalytical (potentiometric, polarographic and voltammetric) methods, fluorimetry, flow-injection analysis, etc. are accepted for publication in exceptional cases only, if a unique and substantial advantage over presently known systems is demonstrated. The same applies to the assay of simple drug formulations by any kind of methods and the determination of drugs in biological samples based merely on spiked samples. Drug purity/stability studies should contain information on the structure elucidation of the impurities/degradants.

Metrics from SCImago Journal Rank 2025. View on SCImago